Tendyne Holdings
Abbott Structural Heart is dedicated to improving patient outcomes through innovative, minimally invasive therapies for structural heart diseases. They offer a broad portfolio of solutions including transcatheter and surgical valve replacements, occluders for congenital defects, and devices for stroke risk reduction. With a legacy of over 40 years in heart valve technology and a commitment to clinical evidence, Abbott partners with healthcare providers worldwide to deliver better therapies, evidence, and experiences, aiming to rebuild healthier hearts and improve quality of life.
Industries
Nr. of Employees
small (1-50)
Tendyne Holdings
Patents
Multi-component designs for heart valve retrieval device, sealing structures and stent assembly
US-11759318-B2
View Details
Multi-component designs for heart valve retrieval device, sealing structures and stent assembly
US-11759318-B2
View DetailsProducts
Transcatheter mitral valve repair system (TEER)
Minimally invasive clip-based system for edge-to-edge repair of the mitral valve to reduce mitral regurgitation in select patients.
Transcatheter mitral valve replacement system (TMVR)
Transcatheter-delivered mitral bioprosthesis with anchoring/tethering mechanisms for replacement of the native mitral valve in selected anatomies.
Transcatheter aortic valve implantation (TAVI) system
Self-expanding transcatheter aortic valve and dedicated delivery system designed for controlled deployment and optimized hemodynamics in patients with aortic stenosis.
Surgical stented tissue valves (aortic and mitral)
Stented biological tissue valves intended for surgical replacement of diseased native or prosthetic aortic and mitral valves with designs optimized for hemodynamics and future interventions.
Mechanical heart valves
Mechanical prosthetic heart valves designed for long-term structural integrity and durability for patients requiring mechanical valve replacement.
Left atrial appendage occlusion device
Percutaneous occlusion device delivered via transseptal access and imaging guidance to seal the left atrial appendage for stroke risk reduction in nonvalvular atrial fibrillation patients.
Transcatheter mitral valve repair system (TEER)
Minimally invasive clip-based system for edge-to-edge repair of the mitral valve to reduce mitral regurgitation in select patients.
Transcatheter mitral valve replacement system (TMVR)
Transcatheter-delivered mitral bioprosthesis with anchoring/tethering mechanisms for replacement of the native mitral valve in selected anatomies.
Transcatheter aortic valve implantation (TAVI) system
Self-expanding transcatheter aortic valve and dedicated delivery system designed for controlled deployment and optimized hemodynamics in patients with aortic stenosis.
Surgical stented tissue valves (aortic and mitral)
Stented biological tissue valves intended for surgical replacement of diseased native or prosthetic aortic and mitral valves with designs optimized for hemodynamics and future interventions.
Mechanical heart valves
Mechanical prosthetic heart valves designed for long-term structural integrity and durability for patients requiring mechanical valve replacement.
Left atrial appendage occlusion device
Percutaneous occlusion device delivered via transseptal access and imaging guidance to seal the left atrial appendage for stroke risk reduction in nonvalvular atrial fibrillation patients.
Services
On-site and remote training programs, initial proctorship for new centers, and ongoing case monitoring to support procedural adoption.
Design and conduct of multicenter prospective randomized and single-arm clinical investigations for structural heart devices, including endpoint definition and site coordination.
Post-approval and observational study services to collect real-world outcomes, fulfill PMCF requirements, and generate clinical insights and data cards.
Support for patient selection, imaging protocol optimization, intra-procedural imaging interpretation, and troubleshooting complex scenarios.
Support mechanisms for investigator-initiated research including study facilitation and grant/charitable donation programs.
On-site and remote training programs, initial proctorship for new centers, and ongoing case monitoring to support procedural adoption.
Design and conduct of multicenter prospective randomized and single-arm clinical investigations for structural heart devices, including endpoint definition and site coordination.
Post-approval and observational study services to collect real-world outcomes, fulfill PMCF requirements, and generate clinical insights and data cards.
Support for patient selection, imaging protocol optimization, intra-procedural imaging interpretation, and troubleshooting complex scenarios.
Support mechanisms for investigator-initiated research including study facilitation and grant/charitable donation programs.
Expertise Areas
- Structural heart device development
- Transcatheter valve therapies (TAVI, TMVR)
- Transcatheter edge-to-edge repair (TEER) for mitral and tricuspid valves
- Occluder-based structural interventions (LAA, PFO, ASD, VSD, PDA, PVL)
Key Technologies
- Transcatheter delivery systems (transfemoral, transseptal, subclavian/axillary)
- Echocardiography-guided interventions (TEE/TTE) for device placement
- Fluoroscopic imaging for catheter navigation
- Active sealing cuff design for paravalvular leak reduction